Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumors-Reference-Cited by-同舟云学术

Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumors

Published:2013-08-18 Issue:12 Volume:21 Page:3483-3490
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Van den Wyngaert T.,Delforge M.,Doyen C.,Duck L.,Wouters K.,Delabaye I.,Wouters C.,Wildiers H.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-013-1934-0.pdf

Reference39 articles.

1. Raje N, Roodman GD (2011) Advances in the biology and treatment of bone disease in multiple myeloma. Clin Cancer Res 17:1278–1286

2. Weilbaecher KN, Guise TA, McCauley LK (2011) Cancer to bone: a fatal attraction. Nat Rev Cancer 11:411–425

3. Coleman RE (2004) Bisphosphonates: clinical experience. Oncologist 9(Suppl 4):14–27

4. Kohno N, Aogi K, Minami H, Nakamura S, Asaga T, Iino Y, Watanabe T, Goessl C, Ohashi Y, Takashima S (2005) Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial. J Clin Oncol 23:3314–3321

5. Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Zheng M (2004) Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 96:879–882

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the complexities and controversies of medication-related osteonecrosis of the jaw (MRONJ): a critical update and consensus statement;Acta Chirurgica Belgica;2023-12-08

2. Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents — A retrospective study of 240 patients;Bone;2023-05

3. Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center;The Saudi Dental Journal;2022-09

4. Radiographic predictors for MRONJ in oncologic patients undergoing tooth extraction;Scientific Reports;2022-07-04

5. Comparative Treatment Persistence with Bone-Targeting Agents Among Asian Patients with Bone Metastases from Solid Tumors: A Multinational Retrospective Cohort Study;BioDrugs;2022-04-12